Kate Pretty Lecture 2018
The second lecture in this new series was entitled 'What Science Can Do: The Cambridge life science cluster at a pivot point', and was delivered by the CEO of AstraZeneca, Pascal Soriot, in his first public lecture in Cambridge. AstraZeneca's new £500 million global research and development centre is under construction on the Cambridge Biomedical Campus, and the College counts senior AZ researchers Professor Tim Eisen and Professor Steve Rennard among the Fellowship.
Healthcare is undergoing a transformation, driven by data, computing power and smart techniques such as AI... We believe that, by being here in Cambridge, we can collaborate with some of the best scientists in the world.
This lecture took place on 8 March 2018, with 220 guests in the audience, from the University and the general public.
The full lecture is now available: